Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
Sanome has secured Class IIb CE certification and MHRA approval for MEMORI - an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs).
Read more here.
Driven by demand, Conexen are hoping to launch a new community in Manchester this October. They have an amazing team of local executives ready to go and excited to bring everybody in life sciences, biopharma and health together.
Contact them:…
Attendees
Sponsors and Exhibitors
Contact us